How can Ozempic and Wegovy influence taste?

When it comes to weight loss, we know that semaglutide works by slowing down digestion and reducing appetite, so people taking the medication tend to feel full sooner and eat less. But, a recent study suggests another mechanism may be at work: taste. Researchers found that semaglutide may influence taste sensitivity and could even alter how sweet tastes are processed in your brain. Read on to learn more about how these weight loss medications may affect your taste buds, too. 

Semaglutide is the active ingredient in the diabetes medication Ozempic and weight loss drug Wegovy. (Both medications are also approved to reduce cardiovascular risk in people with known heart disease and either type 2 diabetes or obesity.) 

Semaglutide belongs to a category of prescription medications known as GLP-1s. Short for glucagon-like peptide-1, GLP-1 is a gut hormone your body creates after you eat to regulate your appetite and blood sugar levels. GLP-1 drugs like Ozempic and Wegovy work by mimicking this hormone. So do other drugs in the category, including Saxenda (liraglutide), Trulicity (dulaglutide), and Mounjaro and Zepbound (tirzepatide). 

After you eat, these medications can help keep blood sugar levels in check. They also help with weight loss. Put simply, GLP-1s lower appetite and increase satiety (fullness), leading to weight loss. But that may not be the whole story. 

Previous research has found that semaglutide also affects your cravings for certain foods. People taking the medication report having more control over their eating, and being less interested in high-fat, calorie-dense foods—as well as salty, spicy, dairy, and starchy foods. Additionally, animal studies have found that GLP-1 may impact areas of the brain involved in appetite regulation and reward perception. Now, a new study suggests an impact on taste perception as well.

Semaglutide may affect taste perception, taste bud gene expression, and brain activity in response to sweet tastes, according to research findings presented at the Endocrine Society's annual meeting, ENDO 2024. In the study, the scientists observed the effects of semaglutide in a group of 30 women with obesity (average BMI of 36.4) over the course of 16 weeks. Half of the participants took a 1 milligram (mg) weekly dose of Ozempic, while the others took a placebo. The researchers looked at three aspects of taste, including:

1. Taste sensitivity: This was measured using strips that had concentrations of the four basic tastes: sweet, bitter, salty, and sour.

2. Taste bud gene expression: A tongue biopsy revealed how participants responded to taste at a genetic level.

3. Brain activity: Using MRIs, researchers observed how their brains responded to having a sweet solution dripped onto their tongue before and after eating a meal.

At the end of the study, the women taking semaglutide displayed an improved sensitivity to taste compared to those taking a placebo. Their tongue biopsies revealed that the genes involved in taste perception and taste bud renewal were more active. Their brains, especially the part of the brain called the angular gyrus, showed increased activity when tasting a sweet solution. Located in the parietal cortex, the angular gyrus is involved in a number of functions, including memory retrieval, semantic processing, and reasoning. 

While these findings are exciting, the researchers did caveat that the study was small (only 30 people, all of whom were women), and that the response to taste in a study environment may not translate to a real-world environment. However, previous animal studies have reported similar findings: wild mice with a healthy GLP-1 receptor had a stronger response to sweet tastes than those missing the receptor.

It may not surprise you to learn that taste isn’t universal. Factors as wide-ranging as your age, your gender, whether you smoke or drink, your menstrual cycle (if you have one), and the medications you take can all impact your sense of taste. People perceive tastes differently, and that can affect the foods they gravitate towards, and how much of those foods they eat.

People with type 2 diabetes or obesity—both conditions that semaglutide treats—may have a lower sense of taste compared to people without those conditions. Obesity has been linked to changes in the feedback loop between your taste buds and your brain. And some research has found that as body mass index (BMI) increases, taste sensitivity decreases.

In particular, people with obesity may have a reduced sensitivity to sweet tastes. “People with obesity have a blunted response to sweets, so they need to eat more of it to get the same reward. They’re eating more, but they’re not getting as much pleasure from it as someone who is not obese,” shares Dr. Charlie Seltzer, MD, a board-certified physician in obesity medicine and internal medicine and a Certified Strength and Conditioning Specialist. While metabolism plays a role in weight gain or loss, he says, appetite and intake have a larger impact. 

At the same time, people with obesity may find sweet-tasting food more desirable. This puts them in a tough spot when it comes to weight loss, since calorie-dense foods tend to be tastier. “Their receptors are more attracted to sweets and dense foods,” shares Dr. Dina Peralta-Reich, MD, a physician holding dual board certifications in Pediatrics and Obesity Medicine, and the founder and director of New York Weight Wellness Medicine. “They perceive tastes less intensely, but they have an elevated desire for high-calorie foods like pasta, pastries, breads, and creamy, heavy foods.”

If taking GLP-1 drugs like semaglutide increases a person’s sensitivity to sweet tastes, as the research suggests, it may explain yet another way the drugs lead to weight loss. “When you have this increased sensitization from the GLP-1s, it drops your appetite, so you end up eating less and lose weight,” says Dr. Seltzer.

That increased sensitivity may extend to other foods as well, making them more pleasurable and enticing to people taking GLP-1s, says Dr. Peralta-Reich. “People with obesity on GLP-1s start to experience tastes more intensely, but not only for sweet and dense foods. It opens your horizons to different foods that you are more willing to eat.”

While this is just one small study, it adds to a body of research that suggests our sense of taste plays a role in weight gain or loss. Previous studies have suggested that some aspects of obesity, including taste and reward, can be reversed. People who exercise more often—which is recommended when taking semaglutide—tend to rate sweet tastes as more intense according to a small study in men, so they may consume fewer calories. 

Semaglutide, the active ingredient in Wegovy and Ozempic, has been hailed for its ability to treat type 2 diabetes, produce weight loss, and reduce cardiovascular risk. This latest study suggests semaglutide may also improve taste sensitivity in adults with obesity, especially for sweet tastes, but more research is needed to confirm these findings.

If you’re interested in semaglutide, a Ro provider can discuss your goals and help you determine whether weight loss medication may be right for you.

---

How we reviewed this article

Every article on Health Guide goes through rigorous fact-checking by our team of medical reviewers. Our reviewers are trained medical professionals who ensure each article contains the most up-to-date information, and that medical details have been correctly interpreted by the writer.

Editorial Guidelines | Medical Review Process

Current version

July 03, 2024

Written by

Amelia Willson

Fact checked by

Patricia Weiser, PharmD

---

About the medical reviewer

Patricia Weiser, PharmD

Patricia Weiser, PharmD, is a licensed pharmacist, health content writer, and medical reviewer with more than a decade of clinical experience in community and hospital pharmacy.